High-Purity SS-31: Synthesis & Manufacturing | Palmetto Peptides

Synthesis and Manufacturing Processes for High-Purity SS-31 Research Peptide

Research Notice: This article covers research on SS-31 research peptide and MOTS-C research peptide — available from Palmetto Peptides for laboratory use only.

Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in vitro and legitimate laboratory research purposes. They are not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines.

Research Disclaimer: SS-31 is sold by Palmetto Peptides strictly as a research compound for in vitro and laboratory use only.

For a complete overview of this research area, see the Complete Guide to SS-31 (Elamipretide) Research Peptide from Palmetto Peptides.

Understanding how SS-31 is manufactured helps researchers evaluate material reliability. A well-synthesized and properly purified SS-31 batch is the foundation of reproducible mitochondrial research. Researchers can source high-purity SS-31 research peptide from Palmetto Peptides. For related context: BPC-157 research peptide science and NAD+ peptide research.

Last Updated: April 21, 2026 | Reading Time: Approximately 2 minutes | Author: Palmetto Peptides Research Team

Quick Answer

Solid-Phase Peptide Synthesis (SPPS): The Method

SS-31 is manufactured by Fmoc SPPS — the industry standard for research-grade peptides. The four residues (D-Arg, Dmt, Lys, Phe) are assembled sequentially C-to-N on a resin support. Unreacted reagents are washed away between each coupling step. After assembly, global deprotection and resin cleavage yield crude SS-31 for purification.

Researchers seeking a broader review can consult the Complete Guide to SS-31 (Elamipretide) Research Peptide, which covers the full research landscape in detail.

The Fmoc SPPS Cycle

Coupling: Fmoc-protected amino acid + activating reagent reacts with free amine on resin-bound chain (30-60 min)

Fmoc Deprotection: 20% piperidine in DMF removes Fmoc protecting group

Washing: DMF washes remove piperidine and byproducts

Repeat for all four residues

Global cleavage: TFA cocktail removes side chain protecting groups and cleaves peptide from resin

The Special Challenges: Dmt and D-Arg

2',6'-Dimethyltyrosine (Dmt)

Dmt is not in standard amino acid libraries. Its sterically hindered ring slows coupling kinetics, requiring optimized protocols — extended coupling times, double-coupling, or highly activated reagents — to avoid truncation impurities.

D-Arginine

Requires the D-configured Fmoc-protected building block. The Pbf protecting group on the guanidinium side chain must be fully removed in the final cleavage step to avoid mass-shifted impurities.

Purification and Final Product

Crude SS-31 (typically 50-80% purity) undergoes preparative RP-HPLC, fraction pooling, analytical HPLC verification, and lyophilization to produce final dry powder at >=95-98% purity. See also: MOTS-C research, mitochondrial function research, longevity peptide research. Order SS-31 here.

Frequently Asked Questions

How is SS-31 synthesized?

By Fmoc SPPS: four residues assembled sequentially on resin, cleaved, deprotected, and purified by RP-HPLC.

What makes SS-31 synthesis challenging?

The non-standard Dmt building block and D-arginine residue require specialized protocols to achieve high purity without truncation or racemization impurities.

See Also: SS-31 Research Peptide: Complete Guide

Related Research

Analytical Methods for Verifying SS-31 Research Peptide Identity and Purity in the Lab

Buying Guide: How to Select High-Quality SS-31 Research Peptide from Reputable Lab Suppliers

History and Development of Szeto-Schiller SS Peptides: The Research Origins of SS-31